HealthEquity, Inc. (NASDAQ:HQY) Receives $96.17 Consensus PT from Analysts

HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) has earned an average rating of "Buy" from the eleven analysts that are currently covering the company, Marketbeat reports. Eleven equities research analysts have rated the stock with a buy rating. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $96.17.

A number of equities analysts have issued reports on the company. JPMorgan Chase & Co. increased their price target on HealthEquity from $86.00 to $108.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 2nd. Barclays lifted their price target on shares of HealthEquity from $84.00 to $104.00 and gave the company an "overweight" rating in a research note on Friday, February 23rd. Bank of America upped their price objective on shares of HealthEquity from $93.00 to $97.00 and gave the stock a "buy" rating in a research report on Wednesday, March 20th. Royal Bank of Canada lifted their target price on shares of HealthEquity from $90.00 to $92.00 and gave the company an "outperform" rating in a research report on Wednesday, March 20th. Finally, JMP Securities started coverage on shares of HealthEquity in a research note on Thursday, April 4th. They set a "mkt outperform" rating and a $101.00 target price for the company.

Insiders Place Their Bets

In other HealthEquity news, EVP Delano Ladd sold 2,558 shares of the business's stock in a transaction on Friday, March 1st. The stock was sold at an average price of $82.59, for a total transaction of $211,265.22. Following the transaction, the executive vice president now owns 47,438 shares of the company's stock, valued at $3,917,904.42. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, Director Evelyn S. Dilsaver sold 32,500 shares of the stock in a transaction that occurred on Tuesday, March 26th. The shares were sold at an average price of $79.29, for a total value of $2,576,925.00. Following the completion of the sale, the director now owns 32,123 shares of the company's stock, valued at approximately $2,547,032.67. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Delano Ladd sold 2,558 shares of HealthEquity stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of $82.59, for a total transaction of $211,265.22. Following the sale, the executive vice president now directly owns 47,438 shares in the company, valued at approximately $3,917,904.42. The disclosure for this sale can be found here. Insiders have sold 71,322 shares of company stock valued at $5,682,895 in the last ninety days. 2.70% of the stock is currently owned by corporate insiders.

Institutional Trading of HealthEquity

Several institutional investors and hedge funds have recently bought and sold shares of HQY. Rise Advisors LLC acquired a new stake in HealthEquity in the 1st quarter valued at approximately $28,000. Cape Investment Advisory Inc. purchased a new position in shares of HealthEquity during the fourth quarter worth $27,000. McGlone Suttner Wealth Management Inc. acquired a new stake in shares of HealthEquity in the fourth quarter valued at $29,000. YHB Investment Advisors Inc. purchased a new stake in shares of HealthEquity in the 1st quarter valued at $40,000. Finally, DekaBank Deutsche Girozentrale acquired a new position in HealthEquity during the 3rd quarter worth about $41,000. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

HealthEquity Stock Performance

Shares of HQY traded down $1.39 during trading hours on Tuesday, hitting $78.91. The stock had a trading volume of 481,175 shares, compared to its average volume of 593,529. The firm has a 50-day moving average price of $80.99 and a 200 day moving average price of $74.53. HealthEquity has a fifty-two week low of $48.86 and a fifty-two week high of $84.49. The firm has a market capitalization of $6.77 billion, a price-to-earnings ratio of 125.47, a PEG ratio of 1.31 and a beta of 0.53. The company has a debt-to-equity ratio of 0.43, a quick ratio of 4.76 and a current ratio of 4.76.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings data on Tuesday, March 19th. The company reported $0.50 earnings per share for the quarter, topping analysts' consensus estimates of $0.42 by $0.08. HealthEquity had a net margin of 5.57% and a return on equity of 6.91%. The business had revenue of $262.39 million during the quarter, compared to the consensus estimate of $258.56 million. As a group, research analysts anticipate that HealthEquity will post 2.12 EPS for the current year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.